SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,123.83 -125.56
( -0.17%)

Global Indices

Nasdaq

52,230.09 -658.89
(-1.25%)

Dow Jones

7,644.13 -40.30
(-0.52%)

Hang Seng

62,584.98 -322.86
(-0.51%)

Nikkei 225

10,670.63 -54.40
(-0.51%)

Forex

USD-INR

94.61 0.10
(0.11%)

EUR-INR

106.18 0.08
(0.07%)

GBP-INR

126.70 0.19
(0.15%)

JPY-INR

0.60 0.00
(0.70%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Makers Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

506919

INE987A01010

92.2552664

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MAKERSL

113.29

EPS(TTM)

Face Value()

Div & Yield %

Back

Board of Remus Pharmaceuticals recommends final dividend

May 21,2026

Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 20 May 2026, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 5%) , subject to the approval of the shareholders.

73,123.83 -125.56 ( -0.17%)

52,230.09 -658.89 (-1.25%)

7,644.13 -40.30 (-0.52%)

62,584.98 -322.86 (-0.51%)

10,670.63 -54.40 (-0.51%)

94.61 0.10 (0.11%)

106.18 0.08 (0.07%)

126.70 0.19 (0.15%)

0.60 0.00 (0.70%)